March 4 (Reuters) - PIXIUM VISION SA ALPIX.PA :
* ANNOUNCES PRIMA SYSTEM SUCCESSFUL ACTIVATION IN FIRST
PATIENT IN
US FEASIBILITY STUDY WITH THE NEW GENERATION OF GLASSES
* SECOND PATIENT HAS ALSO BEEN IMPLANTED AND SHOULD BE
ACTIVATED
SHORTLY
* SAYS THESE STUDIES WILL SUPPORT UPCOMING PRIMAVERA TRIAL
IN DRY
AMD ON TRACK TO BE FILED IN H1 2020 - CEO
* SAYS LOOKING FORWARD TO REPORTING IN Q1 2020, 18-MONTH
DATA FROM
PATIENTS IN FRANCE WHO HAVE TRANSITIONED TO NEWEST GENERATION
PRIMA SYSTEM
* EXPECTS TO START PRIMAVERA IN 2020 WHICH WILL PAVE WAY FOR
REGULATORY APPROVAL," SAYS LLOYD DIAMOND, CHIEF EXECUTIVE
OFFICER OF PIXIUM VISION"
Source text for Eikon: ID:nGNE88CrWz
Further company coverage: ALPIX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587785110;))